Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

10 Up-and-Coming Healthcare Medical Innovations

December 18, 2014 12:10 pm | by Christina Jakubowski, Managing Editor, Bioscience Technology | Articles | Comments

The Cleveland Clinic recently unveiled their annual Top 10 Medical Innovations for 2015– a list that casts an optimistic light on up-and-coming healthcare advances that may reach consumers next year. Their number one? Read more...                         

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Company Pioneers High Performance Anti-Pruritus Nanopatch

December 19, 2014 10:06 am | News | Comments

A Hong Kong company successfully developed and registered the world's first ever high-performance anti-pruritus nanopatch. Read more...                     

TOPICS:

Merck Buys Swiss Biotech Firm With Promising Cancer Drug

December 19, 2014 8:50 am | News | Comments

Merck is buying a biotech company based in Switzerland that is making a promising cancer drug. Read more...                          

TOPICS:

China Pledges to Speed Entry of U.S. Pharmaceuticals

December 19, 2014 8:37 am | by Jason Keyser - Associated Press | News | Comments

China promised Thursday to speed up imports of pharmaceuticals and medical devices from the United States. Read more...                         

TOPICS:
Advertisement

New Report: Hep C's Decades of Drug Research Failures, Successes

December 18, 2014 5:18 pm | by PhRMA | News | Comments

PhRMA released a new report, "Twenty-Five Years of Progress Against Hepatitis C: Setbacks and Stepping Stones," that examines the scientific challenges and setbacks researchers have faced on the path to developing new medicines with the potential to transform treatment for hepatitis C patients and how these so-called "failures" are an integral part of the drug discovery process. Read more...

TOPICS:

New Disease Mechanism Discovered in Lymphoma

December 18, 2014 11:34 am | by Technical University - Munich | News | Comments

Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor growth. Read more...                          

TOPICS:

Warehouse Holding Ebola Supplies in Guinea Catches Fire

December 18, 2014 11:28 am | by Boubacar Diallo - Associated Press | News | Comments

A Guinean official says a fire at a warehouse at the Conakry airport has destroyed crucial medicine to help fight Ebola. Dr. Moussa Konate, head of logistics for Guinea's Ebola response, said that the fire on Thursday morning engulfed a building holding medicine, like anti-malarials and antibiotics. Read more...

TOPICS:

Hypertension Medication that Targets Stress May Help Smokers Quit

December 18, 2014 11:23 am | by Daniel Jones, Yale University | News | Comments

Smokers trying to quit often light up a cigarette to deal with stress. Now an interdisciplinary team of Yale researchers has shown that guanfacine, a medication approved for treating hypertension that reduces stress and enhances cognition, shows promise as a smoking cessation aid. Read more...

TOPICS:

Microcapsule Eliminates Toxic Punch of Experimental Anti-Cancer Drug

December 18, 2014 11:15 am | by Johns Hopkins | News | Comments

Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pancreatic cancer tissue. Read more..

TOPICS:
Advertisement

Inovio Initiates DNA Immunotherapy Trial for Cancers

December 18, 2014 10:48 am | News | Comments

Inovio Pharmaceuticals, Inc. announced it has initiated a phase 1 trial of its hTERT DNA immunotherapy (INO-1400) alone or in combination with Inovio's 1L-12 immune activator (INO-9012) in adults with breast, lung, or pancreatic cancer at high risk of relapse after surgery and other cancer treatments. Read more...

TOPICS:

GSK Shingles Vaccine Hits Goal in Major Study

December 18, 2014 9:02 am | News | Comments

GSK announced that a pivotal phase 3 study to assess the efficacy of HZ/su, an investigational vaccine for the prevention of shingles, has met its primary endpoint. Read more...                                 

TOPICS:

Fresh Setback For Efforts to Cure HIV Infection

December 18, 2014 8:12 am | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

Researchers are reporting another disappointment for efforts to cure infection with the AIDS virus. Read more...                         

TOPICS:

Chikungunya Virus Shuts Down Infected Cells

December 17, 2014 4:59 pm | by Wageningen University | News | Comments

Researchers from Wageningen University, part of Wageningen UR, in collaboration with colleagues from Leiden University and a research team in Australia, have revealed how chikungunya virus blocks essential processes in infected cells that normally would keep the virus under control. Read more...

TOPICS:

Despite Risks, Benzodiazepine Use Highest in Older People

December 17, 2014 4:50 pm | by NIH | News | Comments

Prescription use of benzodiazepines — a widely used class of sedative and anti-anxiety medications — increases steadily with age, despite the known risks for older people, according to a comprehensive analysis of benzodiazepine prescribing in the United States. Read more...

TOPICS:

Stem Cell Prompting Deadly Fibrosis Found

December 17, 2014 4:35 pm | by Cynthia Fox, Science Writer | Articles | Comments

Some 45% of deaths are caused by fibrosis (scar tissue) diseases, including idiopathic pulmonary fibrosis, cirrhosis, and heart and kidney failure. But a Harvard University group reports in Cell Stem Cell they have discovered a key cause of that fibrosis: a stem-cell-like perivascular cell called Gli1+, found in blood vessels. Read more...

TOPICS:

Study: Removing Clot Helps Limit Stroke Disability

December 17, 2014 2:25 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

A new treatment has been shown to limit the damage from a common type of stroke. Read more...                           

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading